281. Sedation practices for routine gastrointestinal endoscopy: a systematic review of recommendations.
作者: Fahima Dossa.;Olivia Megetto.;Mafo Yakubu.;David D Q Zhang.;Nancy N Baxter.
来源: BMC Gastroenterol. 2021年21卷1期22页
Sedation is commonly used in gastrointestinal endoscopy; however, considerable variability in sedation practices has been reported. The objective of this review was to identify and synthesize existing recommendations on sedation practices for routine gastrointestinal endoscopy procedures.
282. Alterations in short-chain fatty acids and serotonin in irritable bowel syndrome: a systematic review and meta-analysis.
Short-chain fatty acids (SCFAs) and serotonin (5-hydroxytryptamine, 5-HT) may be associated with the pathogenesis of irritable bowel syndrome (IBS). There are some reports of alterations in SCFAs and 5-HT in IBS, but their results are inconsistent. We aimed to perform a meta-analysis to assess alterations in SCFAs and 5-HT in IBS patients and their potential role in the abnormal brain-gut-microbiota (BGM) axis.
283. Application of artificial intelligence in chronic liver diseases: a systematic review and meta-analysis.
作者: Pakanat Decharatanachart.;Roongruedee Chaiteerakij.;Thodsawit Tiyarattanachai.;Sombat Treeprasertsuk.
来源: BMC Gastroenterol. 2021年21卷1期10页
The gold standard for the diagnosis of liver fibrosis and nonalcoholic fatty liver disease (NAFLD) is liver biopsy. Various noninvasive modalities, e.g., ultrasonography, elastography and clinical predictive scores, have been used as alternatives to liver biopsy, with limited performance. Recently, artificial intelligence (AI) models have been developed and integrated into noninvasive diagnostic tools to improve their performance.
284. Prognostic Factors for Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: Systematic Review and Meta-analysis.
作者: Anouk M Wijnands.;Michiel E de Jong.;Maurice W M D Lutgens.;Frank Hoentjen.;Sjoerd G Elias.;Bas Oldenburg.; .
来源: Gastroenterology. 2021年160卷5期1584-1598页
Patients with inflammatory bowel disease (IBD) have an increased risk of colorectal cancer (CRC). We performed a systematic review and meta-analysis to identify all prognostic factors for advanced colorectal neoplasia (aCRN, high-grade dysplasia, or CRC) in patients with IBD.
285. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.
作者: Dan Turner.;Amanda Ricciuto.;Ayanna Lewis.;Ferdinando D'Amico.;Jasbir Dhaliwal.;Anne M Griffiths.;Dominik Bettenworth.;William J Sandborn.;Bruce E Sands.;Walter Reinisch.;Jürgen Schölmerich.;Willem Bemelman.;Silvio Danese.;Jean Yves Mary.;David Rubin.;Jean-Frederic Colombel.;Laurent Peyrin-Biroulet.;Iris Dotan.;Maria T Abreu.;Axel Dignass.; .
来源: Gastroenterology. 2021年160卷5期1570-1583页
The Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative of the International Organization for the Study of Inflammatory Bowel Diseases (IOIBD) has proposed treatment targets in 2015 for adult patients with inflammatory bowel disease (IBD). We aimed to update the original STRIDE statements for incorporating treatment targets in both adult and pediatric IBD.
286. The effects of resistant starches on inflammatory bowel disease in preclinical and clinical settings: a systematic review and meta-analysis.
作者: Joshua Montroy.;Rania Berjawi.;Manoj M Lalu.;Eyal Podolsky.;Cayden Peixoto.;Levent Sahin.;Alain Stintzi.;David Mack.;Dean A Fergusson.
来源: BMC Gastroenterol. 2020年20卷1期372页
Inflammatory bowel disease (IBD) is a debilitating chronic disease with limited treatment options. Resistant starches may represent a novel treatment for IBD. However, its efficacy and safety remain unclear. Our objective was to perform a systematic review to summarize the preclinical and clinical effects of resistant starch, which may help guide future studies.
287. Adverse events of video capsule endoscopy over the past two decades: a systematic review and proportion meta-analysis.
作者: Yuan-Chen Wang.;Jun Pan.;Ya-Wei Liu.;Feng-Yuan Sun.;Yang-Yang Qian.;Xi Jiang.;Wen-Bin Zou.;Ji Xia.;Bin Jiang.;Nan Ru.;Jia-Hui Zhu.;En-Qiang Linghu.;Zhao-Shen Li.;Zhuan Liao.
来源: BMC Gastroenterol. 2020年20卷1期364页
A full spectrum of video capsule endoscopy (VCE) adverse events over the past two decades has not been evaluated. We aimed to determine pooled rates, predictors and temporal-trend of VCE adverse events over the past two decades.
288. The clinical efficacy and adverse effects of Entecavir plus Thymosin alpha-1 combination therapy versus Entecavir Monotherapy in HBV-related cirrhosis: a systematic review and meta-analysis.
作者: Dan Peng.;Hai-Yan Xing.;Chen Li.;Xian-Feng Wang.;Min Hou.;Bin Li.;Jian-Hong Chen.
来源: BMC Gastroenterol. 2020年20卷1期348页
Previous studies have demonstrated the benefits of thymosin alpha-1 (Tα1) in anti-virus, immunological enhancement and anti-inflammation. However, it is controversial about the efficacy and safety of entecavir (ETV) plus Tα1 combination therapy versus ETV monotherapy in cirrhotic patients with hepatitis B virus (HBV) infection.
289. Predicting Outcomes in Pediatric Crohn's Disease for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease-Ahead Program.
作者: Amanda Ricciuto.;Martine Aardoom.;Esther Orlanski-Meyer.;Dan Navon.;Nicholas Carman.;Marina Aloi.;Jiri Bronsky.;Jan Däbritz.;Marla Dubinsky.;Séamus Hussey.;Peter Lewindon.;Javier Martín De Carpi.;Víctor Manuel Navas-López.;Marina Orsi.;Frank M Ruemmele.;Richard K Russell.;Gabor Veres.;Thomas D Walters.;David C Wilson.;Thomas Kaiser.;Lissy de Ridder.;Dan Turner.;Anne M Griffiths.; .
来源: Gastroenterology. 2021年160卷1期403-436.e26页
A better understanding of prognostic factors within the heterogeneous spectrum of pediatric Crohn's disease (CD) should improve patient management and reduce complications. We aimed to identify evidence-based predictors of outcomes with the goal of optimizing individual patient management.
290. Predicting Outcomes in Pediatric Ulcerative Colitis for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease-Ahead Program.
作者: Esther Orlanski-Meyer.;Martine Aardoom.;Amanda Ricciuto.;Dan Navon.;Nicholas Carman.;Marina Aloi.;Jiri Bronsky.;Jan Däbritz.;Marla Dubinsky.;Séamus Hussey.;Peter Lewindon.;Javier Martin De Carpi.;Víctor Manuel Navas-López.;Marina Orsi.;Frank M Ruemmele.;Richard K Russell.;Gabor Veres.;Thomas D Walters.;David C Wilson.;Thomas Kaiser.;Lissy de Ridder.;Anne Griffiths.;Dan Turner.
来源: Gastroenterology. 2021年160卷1期378-402.e22页
A better understanding of prognostic factors in ulcerative colitis (UC) could improve patient management and reduce complications. We aimed to identify evidence-based predictors for outcomes in pediatric UC, which may be used to optimize treatment algorithms.
291. Epidemiology of gastroesophageal reflux disease in Iran: a systematic review and meta-analysis.
作者: Mohammad Karimian.;Hassan Nourmohammadi.;Majid Salamati.;Mohammad Reza Hafezi Ahmadi.;Fatemeh Kazemi.;Milad Azami.
来源: BMC Gastroenterol. 2020年20卷1期297页
Gastroesophageal reflux disease (GERD), which leads to acid reflux into the esophagus, is a common gastrointestinal disorder. Several studies have shown the prevalence of GERD in Iranian population, but their evidence is contradictory. Therefore, the present study was conducted to investigate the epidemiology of GERD in Iran.
292. Comparison of surgical outcomes between isolated pancreaticojejunostomy, isolated gastrojejunostomy, and conventional pancreaticojejunostomy after pancreaticoduodenectomy: a systematic review and meta-analysis.
作者: Yunxiao Lyu.;Bin Wang.;Yunxiao Cheng.;Yueming Xu.;Wei Bing Du.
来源: BMC Gastroenterol. 2020年20卷1期279页
We aimed to compare the safety and effectiveness of the following procedures after pancreaticoduodenectomy: isolated pancreaticojejunostomy, isolated gastrojejunostomy, and conventional pancreaticojejunostomy.
293. Association of Helicobacter pylori vacA genotypes and peptic ulcer in Iranian population: a systematic review and meta-analysis.
作者: Masoud Keikha.;Mohammad Ali-Hassanzadeh.;Mohsen Karbalaei.
来源: BMC Gastroenterol. 2020年20卷1期266页
Helicobacter pylori is accounted as the most etiologic agent for digestive disorders, in particular, the most important of them i.e. peptic ulcer and gastric cancer. In the recent years, association of vacA genotypes and gastrointestinal disorders has attracted a lot of attention. In present study, we assessed the correlation between vacA genotypes (s1, s2, m1, m2, s1m1, s1m2, s2m1 and s2m2) and development to peptic ulcer in Iranian population.
294. The role of circulating microRNAs for the diagnosis of hepatitis B virus-associated hepatocellular carcinoma with low alpha-fetoprotein level: a systematic review and meta-analysis.
作者: Cheng Peng.;Zhuonan Li.;Zishan Xie.;Zhanpeng Wang.;Yanshuo Ye.;Bo Li.;Wei Li.
来源: BMC Gastroenterol. 2020年20卷1期249页
Alpha-fetoprotein (AFP) has been widely used for many years as a serum marker for hepatocellular carcinoma (HCC). However, AFP has been recognized as having poor sensitivity. More and more studies have concluded that circulating microRNAs (miRNAs) might be a promising biomarker that could complement AFP. However, the diagnostic ability of circulating miRNAs has varied among the studies. Therefore, we performed the present meta-analysis to appraise the diagnostic performance of circulating miRNAs as a biomarker for hepatitis B virus-associated HCC (HBV-HCC) patients with low AFP levels.
295. Misdiagnosis of peripheral abscess caused by duodenal foreign body: a case report and literature review.
作者: Zhihui Wang.;Zhiqiang Du.;Xiangrong Zhou.;Tianming Chen.;Chunyan Li.
来源: BMC Gastroenterol. 2020年20卷1期236页
The induction of chronic inflammation, perforation, and abscess by foreign bodies (FBs) in adults is uncommon. We present a delayed diagnosis case for a patient who had a fishbone stuck in the duodenal bulb, resulting in chronic abdominal pain for nearly 3 months. We present the diagnosis and treatment procedures for chronic patients, which differ from those for acute and emergency FB ingestion, and also summarize the characteristics of such patients through a systematic literature review.
297. Probiotics Reduce Mortality and Morbidity in Preterm, Low-Birth-Weight Infants: A Systematic Review and Network Meta-analysis of Randomized Trials.
作者: Rebecca L Morgan.;Geoffrey A Preidis.;Purna C Kashyap.;Adam V Weizman.;Behnam Sadeghirad.; .
来源: Gastroenterology. 2020年159卷2期467-480页
We aimed to compare the effectiveness of single- vs multiple-strain probiotics in a network meta-analysis of randomized trials.
298. Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients With Ulcerative Colitis: A Systematic Review and Meta-Analysis.
作者: Hyuk Yoon.;Sushrut Jangi.;Parambir S Dulai.;Brigid S Boland.;Larry J Prokop.;Vipul Jairath.;Brian G Feagan.;William J Sandborn.;Siddharth Singh.
来源: Gastroenterology. 2020年159卷4期1262-1275.e7页
Clinical remission, defined by a composite of patient reported outcomes and Mayo endoscopy subscore (MES) 0 or 1 is a recommended treatment target in patients with ulcerative colitis (UC). We estimated whether incorporating more rigorous remission definitions, of endoscopic remission (MES 0) and histologic remission, affects risk of relapse.
299. The risk of rheumatoid arthritis among patients with inflammatory bowel disease: a systematic review and meta-analysis.
作者: Yi Chen.;Lang Chen.;Changsheng Xing.;Guangtong Deng.;Furong Zeng.;Tingting Xie.;Lei Gu.;Huixiang Yang.
来源: BMC Gastroenterol. 2020年20卷1期192页
Studies have suggested that patients with inflammatory bowel disease (IBD) have an increased risk of rheumatoid arthritis (RA). However, the available data on this association are inconsistent. This meta-analysis aimed to determine the association between IBD and the risk of RA.
300. Efficacy of serum miRNA test as a non-invasive method to diagnose nonalcoholic steatohepatitis: a systematic review and meta-analysis.
作者: Shengliang Xin.;Qiao Zhan.;Xiaofan Chen.;Jinghang Xu.;Yanyan Yu.
来源: BMC Gastroenterol. 2020年20卷1期186页
Nonalcoholic steatohepatitis (NASH) is a key turning point during the progression of nonalcoholic fatty liver disease (NAFLD). Recent studies have shown that serum miRNA tests may be effective in the diagnosis of NAFLD. We conducted a meta-analysis to assess the evidence for the diagnostic efficacy of serum miRNAs in patients with NAFLD and its subtype, NASH, in particular.
|